Roxane Laboratories clinical trials
Acquired by Hikma Pharmaceuticals, Feb 29, 2016 · source ↗
The registry lists 99 studies whose lead sponsor is Roxane Laboratories. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2018.
Before and after it joined Hikma Pharmaceuticals
- First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- 99
- First submitted after Roxane Laboratories became part of Hikma Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Roxane Laboratories99 studies
Something wrong with this grouping? Tell us on the Hikma Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 50 of 99. List all 99 → · All Hikma Pharmaceuticals studies →
- A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural PainTerminatedNCT01676493Phase 3
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric SubjectsCompletedNCT01322360Phase 4
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted ConditionsCompletedNCT01107353Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602173Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNCT00601874Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting ConditionsCompletedNCT00826865Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed ConditionsCompletedNCT01102465Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Levetiracetam 1g Tablets Under Fed ConditionsCompletedNCT00827320Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Anastrozole 1 mg Under Fed ConditionsCompletedNCT01155089Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted ConditionsCompletedNCT01659931Early Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting ConditionsCompletedNCT00702091Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Zidovudine Under Fed ConditionsCompletedNCT00601562Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted ConditionsCompletedNCT00754962Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed ConditionsCompletedNCT01570894Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Ramipril 10 mg Capsules Under Fed ConditionsCompletedNCT00702260Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 300 mg Lithium Carbonate Under Fed ConditionsCompletedNCT00602394Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Zolpidem Tartrate Under Fasting ConditionsCompletedNCT00601666Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed ConditionsCompletedNCT01367626Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNCT00602550Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed ConditionsCompletedNCT01659892Early Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed ConditionsCompletedNCT01703468Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed ConditionsCompletedNCT01591889Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Food Effect Study of Codeine SulfateCompletedNCT01009892Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted ConditionsCompletedNCT01161667Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Dose Proportionality and Food Effect of Morphine SulfateCompletedNCT00994539Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted ConditionsCompletedNCT01903122Early Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Levetiracetam 1g Under Fasted ConditionsCompletedNCT00826722Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed ConditionsCompletedNCT00893958Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Meloxicam Tablets Under Fasting ConditionsCompletedNCT00618163Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNCT00616863Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNCT00602524Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting ConditionsCompletedNCT00602381Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNCT00674310Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting ConditionsCompletedNCT00616681Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNCT00618046Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted ConditionsCompletedNCT01702623Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted ConditionsCompletedNCT01210638Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted ConditionsCompletedNCT00992095Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed ConditionsCompletedNCT00694317Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Amlodipine Tablets Under Fasting ConditionsCompletedNCT00602017Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed ConditionsCompletedNCT00893919Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Montelukast 10 mg Tablets Under Fed ConditionsCompletedNCT01659918Early Phase 1
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsCompletedNCT00602134Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Zolpidem Tartrate Under Fed ConditionsCompletedNCT00602719Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNCT01712139Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting ConditionsCompletedNCT00601536Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals
- Bioequivalency Study of Exemestane 25 mg Tablet Under Fed ConditionsCompletedNCT01331434Not applicable
Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals